相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Separate and overlapping metabolic functions of LXRα and LXRβ in C57Bl/6 female mice
Marion Korach-Andre et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
PPAR-γ Agonists and Their Role in Type 2 Diabetes Mellitus Management
Valmore Bermudez et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In Vivo
Tomoyuki Yasuda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans
Ashish Shah et al.
ATHEROSCLEROSIS (2010)
Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation
Massimo Collino et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Intestinal Ecology in the Metabolic Syndrome
Michele Petruzzelli et al.
CELL METABOLISM (2010)
PPARs: diverse regulators in energy metabolism and metabolic diseases
Yong-Xu Wang
CELL RESEARCH (2010)
The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2
Cynthia Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cell-Specific Determinants of Peroxisome Proliferator-Activated Receptor γ Function in Adipocytes and Macrophages
Martina I. Lefterova et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
Jang Hyun Choi et al.
NATURE (2010)
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Matam Vijay-Kumar et al.
SCIENCE (2010)
Potent and Selective PPAR-alpha Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
John S. Millar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
Jean-Charles Fruchart
ATHEROSCLEROSIS (2009)
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Manu V. Chakravarthy et al.
CELL (2009)
PPARγ activation in adipocytes is sufficient for systemic insulin sensitization
Shigeki Sugii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
Noam Zelcer et al.
SCIENCE (2009)
Functional implications of genetic variation in human PPAR gamma
Ellen H. Jeninga et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
George Steiner
AMERICAN JOURNAL OF CARDIOLOGY (2008)
After the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study: Implications for Fenofibrate
Frank M. Sacks
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Percutaneous sonographic guidance for TIPS in Budd-Chiari syndrome: Direct simultaneous puncture of the portal vein and inferior vena cava
Fatih Boyvat et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
AMPK and PPARδ Agonists are exercise mimetics
Vihang A. Narkar et al.
CELL (2008)
Hepatic steatosis in leptin-deficient mice is promoted by the PPARγ target gene Fsp27
Kimihiko Matsusue et al.
CELL METABOLISM (2008)
PPAR modulators and PPAR pan agonists for metabolic diseases: The next generation of drugs targeting Peroxisome Proliferator-Activated Receptors?
P. L. Feldman et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Andrew N. Billin
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Dual mechanisms for the fibrate-mediated repression of proprotein convertase subtilisin/kexin type 9
Sanae Kourimate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue
Rinke Stienstra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Antiatherosclerotic Effects of a Novel Synthetic Tissue-Selective Steroidal Liver X Receptor Agonist in Low-Density Lipoprotein Receptor-Deficient Mice
Dacheng Peng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Nuclear hormone receptor expression in the endocrine pancreas
Jen-Chieh Chuang et al.
MOLECULAR ENDOCRINOLOGY (2008)
Cidea is associated with lipid droplets and insulin sensitivity in humans
Vishwajeet Puri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Yasunori Takata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PPARα:: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
Frank J. Gonzalez et al.
TOXICOLOGY (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang Li et al.
CARDIOVASCULAR RESEARCH (2008)
Novel peroxisome proliferator activated receptor-α agonists
Jean-Charles Fruchart
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration
Yoyo T. Y. Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
Diana Jung et al.
JOURNAL OF LIPID RESEARCH (2007)
Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes
Gabriel Pascual et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation
David M. Lonard et al.
MOLECULAR CELL (2007)
New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand
Angelika Luedtke et al.
JOURNAL OF MEDICAL GENETICS (2007)
Regulatory functions of PPARβ in metabolism:: Implications for the treatment of metabolic syndrome
Paul A. Grimaldi
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors
Marie-Louise Ricketts et al.
MOLECULAR ENDOCRINOLOGY (2007)
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
Justin I. Odegaard et al.
NATURE (2007)
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
Andrea L. Hevener et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression
Hironori Waki et al.
CELL METABOLISM (2007)
Effects of a potent and selective PPAR-α agonist in patients with atherogenic dyslipidemia or hypercholesterolemia -: Two randomized controlled trials
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta -87T>C polymorphism and dietary fat in French-Canadians
J. Robitaille et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Triglyceride:: High-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist
Dennis L. Sprecher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The liver X receptor (LXR) and hepatic lipogenesis - The carbohydrate-response element-binding protein is a target gene of LXR
Ji-Young Cha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bile acid sequestrants and the treatment of type 2 diabetes mellitus
Bart Staels et al.
DRUGS (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Adipocyte differentiation from the inside out
Evan D. Rosen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Effects of FXR in foam-cell formation and atherosclerosis development
Grace L. Guo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes
Michael Schuler et al.
CELL METABOLISM (2006)
FXR deficiency causes reduced atherosclerosis in Ldlr-/- mice
Yanqiao Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: Lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor
Gilles Lambert et al.
ENDOCRINOLOGY (2006)
Transcriptional control of adipocyte formation
Stephen R. Farmer
CELL METABOLISM (2006)
Non-DNA binding, dominant-negative, human PPARγ mutations cause lipodystrophic insulin resistance
Maura Agostini et al.
CELL METABOLISM (2006)
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Angie L. Bookout et al.
CELL (2006)
Bile acids induce adhesion molecule expression in endothelial cells through activation of reactive oxygen species, NF-κB, and p38
Pu Qin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Cholesterol gallstone disease
Piero Portincasa et al.
LANCET (2006)
Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans
Yanwen Wang et al.
TRANSLATIONAL RESEARCH (2006)
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Divya Vats et al.
CELL METABOLISM (2006)
Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study
Karpagam Aravindhan et al.
JOURNAL OF LIPID RESEARCH (2006)
Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids
T Frankenberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
KGMM Alberti et al.
DIABETIC MEDICINE (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
S Bilz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Liver X receptors as integrators of metabolic and inflammatory signaling
N Zelcer et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
PPARδ:: a dagger in the heart of the metabolic syndrome
GD Barish et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine
C Duval et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells
FT He et al.
CIRCULATION RESEARCH (2006)
A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids
DM Shih et al.
JOURNAL OF LIPID RESEARCH (2006)
Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4
A Gutierrez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
M Watanabe et al.
NATURE (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy
James F. Tobin et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Role of peroxisome proliferator-activated receptor gamma in glucose-induced insulin secretion
ZK Xu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2006)
FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine
H Lee et al.
JOURNAL OF LIPID RESEARCH (2006)
Molecular characterization of new selective peroxisome proliferator-activated receptor γ modulators with angiotensin receptor blocking activity
M Schupp et al.
DIABETES (2005)
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
EA Hanniman et al.
JOURNAL OF LIPID RESEARCH (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver
SL Sabol et al.
JOURNAL OF LIPID RESEARCH (2005)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
D Duran-Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome
AI Shulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases
E Bedu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes
G Rizzo et al.
MOLECULAR PHARMACOLOGY (2005)
Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues - Association with cytokine expression, insulin resistance, and reduction by pioglitazone
GB Di Gregorio et al.
DIABETES (2005)
LXRβ is required for adipocyte growth, glucose homeostasis, and β cell function
I Gerin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes
A Hiukka et al.
DIABETOLOGIA (2005)
Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome
A Tenenbaum et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Effects of peroxisome proliferator-activated receptor α/δ agonists on HDL-cholesterol in vervet monkeys
JM Wallace et al.
JOURNAL OF LIPID RESEARCH (2005)
Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter
SS Im et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
JR Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Liver X receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways
D Ogawa et al.
CIRCULATION RESEARCH (2005)
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
RS Savkur et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
LXRs regulate the balance between fat storage and oxidation
NY Kalaany et al.
CELL METABOLISM (2005)
Liver X receptor agonists inhibit tissue factor expression in macrophages
N Terasaka et al.
FEBS JOURNAL (2005)
Regulation of carbohydrate metabolism by the farnesoid X receptor
KR Stayrook et al.
ENDOCRINOLOGY (2005)
Regulation of human ApoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor α modulation
H Duez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Oral antihyperglycemic therapy for type 2 diabetes mellitus
AYY Cheng et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1 alpha
RS Savkur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Glucose regulates the expression of the farnesoid X receptor in liver
D Duran-Sandoval et al.
DIABETES (2004)
Expression and activation of the farnesoid X receptor in the vasculature
D Bishop-Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Genetic Polymorphisms in peroxisome proliferator-activated receptor δ associated with obesity
HD Shin et al.
DIABETES (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Identification of DRIP205 as a coactivator for the farnesoid X receptor
IP Torra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1
M Ananthanarayanan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
A Moschetta et al.
NATURE MEDICINE (2004)
Peroxisome proliferator-activated receptor-γ calls for activation in moderation:: Lessons from genetics and pharmacology
C Knouff et al.
ENDOCRINE REVIEWS (2004)
Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia
S Bilz et al.
JOURNAL OF LIPID RESEARCH (2004)
Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4
H Hirokane et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c
H Jakel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
K Yamagata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulation of muscle fiber type and running endurance by PPARδ
YX Wang et al.
PLOS BIOLOGY (2004)
Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
WM He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
T Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Farnesoid X receptor activates transcription of the phospholipid pump MDR3
L Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Muscle-specific Pparg deletion causes insulin resistance
AL Hevener et al.
NATURE MEDICINE (2003)
Liver fatty acid-binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPAR-α in fasting mice
E Erol et al.
FASEB JOURNAL (2003)
Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice
H Koutnikova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse
JW Chisholm et al.
JOURNAL OF LIPID RESEARCH (2003)
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives
MJ Chapman
ATHEROSCLEROSIS (2003)
Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle
E De Fabiani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Efflux and atherosclerosis -: The clinical and biochemical impact of variations in the ABCA1 gene
RR Singaraja et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Farnesoid X receptor regulates bile acid-amino acid conjugation
PC Pircher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Liver X receptor signaling pathways in cardiovascular disease
P Tontonoz et al.
MOLECULAR ENDOCRINOLOGY (2003)
Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators
N Vu-Dac et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue
BA Laffitte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men
J Skogsberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR
M Downes et al.
MOLECULAR CELL (2003)
Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages
A Castrillo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of gene-selective modulators of the bile acid receptor FXR
I Dussault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Bile acids induce the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor
IP Torra et al.
MOLECULAR ENDOCRINOLOGY (2003)
Identification of farnesoid X receptor β as a novel mammalian nuclear receptor sensing lanosterol
K Otte et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
SB Joseph et al.
NATURE MEDICINE (2003)
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
G Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis
GQ Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation
YQ Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP
LJ Borgius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion
LQ Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA
M Nakahara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of macrophage liver X receptors as inhibitors of atherosclerosis
RK Tangirala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The small heterodimer partner interacts with the liver X receptor α and represses its transcriptional activity
C Brendel et al.
MOLECULAR ENDOCRINOLOGY (2002)
Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity
JH Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Accumulation of foam cells in liver X receptor-deficient mice
GU Schuster et al.
CIRCULATION (2002)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
A natural product that lowers cholesterol as an antagonist ligand for FXR
NL Urizar et al.
SCIENCE (2002)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β
JJ Repa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
RM Huber et al.
GENE (2002)
Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors
SB Joseph et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of multidrug resistance-associated protein 2 (ABCC2) by nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor
HR Kast et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Methylation at arginine 17 of histone H3 is linked to gene activation
UM Bauer et al.
EMBO REPORTS (2002)
SREBPs: Transcriptional mediators of lipid homeostasis
JD Horton et al.
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY (2002)
Nuclear receptors and lipid physiology: Opening the X-files
A Chawla et al.
SCIENCE (2001)
Liver X receptor (LXR) regulation of the LMRα gene in human macrophages
KD Whitney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Autoregulation of the human liver X receptor α promoter
BA Laffitte et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
LA Pennacchio et al.
SCIENCE (2001)
PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
N Maeda et al.
DIABETES (2001)
Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor a in HepG2 cells
MH Hsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp
LA Denson et al.
GASTROENTEROLOGY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Genetic basis of sitosterolemia
MH Lee et al.
CURRENT OPINION IN LIPIDOLOGY (2001)
Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial
SJ Robins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein:: A signaling path to the nucleus
C Wolfrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα)
JYL Chiang et al.
GENE (2001)
Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
MH Lee et al.
NATURE GENETICS (2001)
The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
NL Urizar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
KE Berge et al.
SCIENCE (2000)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
L Chao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
A Venkateswaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
CJ Sinal et al.
CELL (2000)
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
B Goodwin et al.
MOLECULAR CELL (2000)
ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR
K Schwartz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Identification of a chemical tool for the orphan nuclear receptor FXR
PR Maloney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study
Z Schlesinger et al.
CIRCULATION (2000)
Apolipoprotein E and atherosclerosis
LK Curtiss et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Activation of PPARδ alters lipid metabolism in db/db mice
MD Leibowitz et al.
FEBS LETTERS (2000)
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
CD Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Pro12Ala polymorphism in PPAR γ2 may confer resistance to type 2 diabetes
K Hara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
Y Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
JJ Repa et al.
SCIENCE (2000)
Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter
H Kim et al.
DIABETES (2000)
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
TT Lu et al.
MOLECULAR CELL (2000)
分享论文
